Toggle light / dark theme

J147 is an experimental drug that has been shown to treat Alzheimer’s disease, and it also appears to reverse some aspects of aging. It is also poised to enter human clinical trials in the near future, although how it works has been somewhat of a puzzle.

A new study published in the journal Aging Cell has changed all that, and the results are quite intriguing[1]. Researchers at the Salk Institute have solved the mystery of how J147 works and why it makes old flies, mice, and cells more youthful.

Read more

What are some of the things you don’t think machines are ever going to be able to do? Computers are still very weak when it comes to understanding. They can’t process a textbook and use the knowledge the way humans do. But that’s being worked on. There’s no real problem- solving limit to what can be done. Understanding what does it mean in terms of consciousness or anything like that, I know that the software won’t be in that realm at all. But it will be an incredible problem solver.


Microsoft founder Bill Gates spoke with TIME’s Nancy Gibbs about looking forward and what makes him optimistic about the future.

Read more

It’s crazy to think that we still don’t quite understand the mechanism behind one of the most common medical interventions — general anaesthetic.

But researchers in Australia just got a step closer by discovering that one of the most commonly used anaesthetic drugs doesn’t just put us to sleep; it also disrupts communication between brain cells.

The team investigated the drug propofol, a super-popular option for surgeries worldwide. A potent sedative, the drug is thought to put us to sleep through its effect on the GABA neurotransmitter system, the main regulator of our sleep-and-wake cycles in the brain.

Read more

It is wartime. You and your fellow refugees are hiding from enemy soldiers, when a baby begins to cry. You cover her mouth to block the sound. If you remove your hand, her crying will draw the attention of the soldiers, who will kill everyone. If you smother the child, you’ll save yourself and the others.

If you were in that situation, which was dramatized in the final episode of the ’70s and ’80s TV series “M.A.S.H.,” what would you do?

The results of a new UCLA study suggest that scientists could make a good guess based on how the responds when watch someone else experience pain. The study found that those responses predict whether people will be inclined to avoid causing harm to others when facing .

Read more

What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects?

That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience.

The international team captured the crystal structure of the kappa opioid receptor—critical for providing pain relief—in action on the surface of human brain cells. The researchers also made another important discovery: a new opioid-based compound that, unlike current opioids, activates only the kappa opioid receptor, raising hopes that they may develop a painkiller that has no risk of addiction and, therefore, none of the devastating consequences and side effects that accompany it.

Read more

A look back at the most popular health articles of 2017. Here is the report: “9 Things Everybody Ought To Know About Fish Oils”


In brief: Do fish oil supplements containing omega-3 fatty acids significantly improve heart health, brain health and a host of other conditions? Here’s what the science says.

Fish oil is the third most widely used supplement in the U.S. According to a study published in 2015 by the National Institutes of Health (NIH), nearly one in twelve Americans used fish oils in 2012.

Omega-3 fatty acids are a group of polyunsaturated fatty acids (PUFA) that are essential for health and are required for some functions in the body. Research studies suggest that omega-3 fatty acids may help in a wide range of diseases, including rheumatoid arthritis, asthma, depression, cancer, ADHD, cardiovascular disease and various autoimmune diseases.

Next, the technology maturation process, unfolds in a linear fashion with the ultimate objective of transitioning to the NASA program that established the requirement. This process sacrifices science and the ability to iterate fast; does not incentivize providers to develop affordable and systematic capabilities, and the consideration of economic intelligence and market pull is anything but strategic (engagement model with industry is secondary, i.e “work for hire” contracts, and commercialization is serendipitous). As the sole customer, NASA/the government needs to maintain the unique infrastructure needed for these missions and maintains large per mission costs.

While science missions are largely competitive and outcome focused, human missions start by establishing a destination — the political choice of Moon or Mars — often becoming a solution in search of a problem. Since the Apollo era, the overall result of this “swing” approach has basically resulted in “grounding” the human space program, negatively affecting the morale of the working force, and making many feel that it is little more than a job welfare program.

From an HR perspective, NASA, like any other government organization, is a great example of Peter’s principle, structured and incentivized by the slogan “the hierarchy needs to be preserved by all costs”, frequently leading to the alienation or outright removal of highly competent people focused on problem solving and with a desire of seeing accelerated progress.

Read more